The Cancer Letter

June

Vol.

No.

June 24, 2022

Harold Varmus reflects on the life of John Edward Porter, a House appropriator—and his friend
Porter helped orchestrate the doubling of the NIH budget between 1998 and 2003

TABLE OF CONTENTS

Vol.

No.

June 17, 2022

Julie Bauman: Washington, DC, needs one more NCI-designated cancer center—and it matters that a woman runs it

TABLE OF CONTENTS

Vol.

No.

June 10, 2022

ASCO’s “rock concert” moments came 17 years apart—in 2005 and 2022
DESTINY-04 results extend HER2-targeted therapy to a larger population in breast cancer

TABLE OF CONTENTS

Vol.

No.

June 03, 2022

#MyFirstASCO: Memories from 57 years of annual meetings

TABLE OF CONTENTS

May

Vol.

No.

May 27, 2022

What cancer centers need to do in the wake of Buffalo, Uvalde shootings

TABLE OF CONTENTS

Vol.

No.

May 20, 2022

Jon Chernoff pledges to revive his institution’s “Fox Chaseness” after years of setbacks

TABLE OF CONTENTS

Vol.

No.

May 13, 2022

Bipartisan misgivings: House appropriators chafe at Biden’s proposal to fund ARPA-H at the expense of NIH

TABLE OF CONTENTS

Vol.

No.

May 06, 2022

FDA’s Lola Fashoyin-Aje: It’s time to increase racial diversity in trials—here’s a draft guidance for how this can be done

TABLE OF CONTENTS

April

Vol.

No.

April 29, 2022

Oncologists, advocates, FDA call for an end to MTD and the “more is better” era in cancer drug dosing

TABLE OF CONTENTS

Vol.

No.

April 22, 2022

ACS recruitment of NCI’s William Dahut illustrates Karen Knudsen’s strategy

TABLE OF CONTENTS

Vol.

No.

April 15, 2022

At ODAC without sponsors, FDA highlights safety signals in PI3K inhibitor trials

TABLE OF CONTENTS

Vol.

No.

April 08, 2022

Ned Sharpless steps down as NCI director

TABLE OF CONTENTS

Vol.

No.

April 01, 2022

In an unprecedented move, Huntsman and Fred Hutch add dramatically to their catchment areas in western U.S.

TABLE OF CONTENTS

March

Vol.

No.

March 25, 2022

James P. Allison Institute at MD Anderson seeks to refocus immunotherapy research

TABLE OF CONTENTS

Vol.

No.

March 18, 2022

DOJ takes over whistleblower suit claiming Memphis Methodist health system and West clinic ran afoul of false claims and anti-kickback laws

TABLE OF CONTENTS

Vol.

No.

March 11, 2022

To help Ukraine’s cancer patients, a coalition of U.S., European cancer groups aims to provide a coordinated response

TABLE OF CONTENTS

Vol.

No.

March 04, 2022

FREE

Ukraine NCI’s Nataliia Verovkina: “We left Kyiv yesterday. We don’t know what will happen with us even in one hour.”

TABLE OF CONTENTS

February

Vol.

No.

February 25, 2022

John Mark Cleland, first man to be cured of metastatic testicular cancer, dies at 71

TABLE OF CONTENTS

Vol.

No.

February 18, 2022

White House’s Danielle Carnival: I’m moving the Cancer Moonshot forward with an all-of-government approach

TABLE OF CONTENTS

Vol.

No.

February 11, 2022

In a 14:1 vote, ODAC nixes a PD-1 drug developed in China; data not generalizable to U.S. population

TABLE OF CONTENTS

Vol.

No.

February 04, 2022

FDA says it had no input as companies developed checkpoint inhibitors in China

TABLE OF CONTENTS

January

Vol.

No.

January 28, 2022

St. Jude, WHO tell us how their $200M initiative would fix global drug shortages for kids with cancer—and (maybe) adults

TABLE OF CONTENTS

Vol.

No.

January 21, 2022

Robert Stone: How City of Hope will go national through acquisition of Cancer Treatment Centers of America

TABLE OF CONTENTS

Vol.

No.

January 14, 2022

Omicron: Is the light at the end of the tunnel (a) pandemic salvation, or (b) an oncoming freight train?

TABLE OF CONTENTS

Vol.

No.

January 07, 2022